Association of single nucleotide polymorphisms of ABCB1, OPRM1 and COMT with pain perception in cancer patients

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 35, Issue 5, 2015, Pages 752-758

  Wang, Xu shi ^a   Song, Hai bin ^b   Chen, Si ^b   Zhang, Wei ^b   Liu, Jia qi ^a   Huang, Chao ^a   Wang, Hao ran ^c   Chen, Yuan ^b   Chu, Qian ^b  

^a Angiocardiopathy Internal Department   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

ABCB1; cancer pain; COMT; OPRM1; pain perception; single nucleotide polymorphisms (SNPs)

Indexed keywords

ABCB1 PROTEIN, HUMAN; CATECHOL METHYLTRANSFERASE; COMT PROTEIN, HUMAN; MU OPIATE RECEPTOR; MULTIDRUG RESISTANCE PROTEIN; OPRM1 PROTEIN, HUMAN;

ADULT; AGED; ALLELE; BREAST NEOPLASMS; COMPLICATION; FEMALE; GASTROINTESTINAL NEOPLASMS; GENE EXPRESSION; GENE FREQUENCY; GENETICS; GENITAL NEOPLASMS, FEMALE; GENITAL NEOPLASMS, MALE; GENOTYPE; HUMAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; NOCICEPTION; PAIN; PAIN MEASUREMENT; PATHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BREAST NEOPLASMS; CATECHOL O-METHYLTRANSFERASE; FEMALE; GASTROINTESTINAL NEOPLASMS; GENE EXPRESSION; GENE FREQUENCY; GENITAL NEOPLASMS, FEMALE; GENITAL NEOPLASMS, MALE; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; P-GLYCOPROTEINS; PAIN; PAIN MEASUREMENT; PAIN PERCEPTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, OPIOID, MU;

EID: 84944676828     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-015-1502-6     Document Type: Article

References (44)

1. Swarm RA, Abernethy AP, Anghelescu DL, et al. Adult cancer pain. J Natl Compr Canc Netw, 2013,11(8): 992–1022
2. Andersen S, Skorpen F. Variation in the COMT gene: implications for pain perception and pain treatment. Pharmacogenomics, 2009,10(4):669–684
3. Yao P, Ding YY, Wang ZB, et al. Effect of gene polymorphism of COMT and OPRM1 on the preoperative pain sensitivity in patients with cancer. Int J Clin Exp Med, 2015,8(6):10036–10039
4. Nackley AG, Shabalina SA, Tchivileva IE, et al. Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science, 2006,314(5807):1930–1933
5. Meloto CB, Segall SK, Smith S, et al. COMT gene locus: new functional variants. Pain, 2015, PMID: 26207649
6. Candiotti KA, Yang Z, Buric D, et al. Catechol-omethyltransferase polymorphisms predict opioid consumption in postoperative pain. Anesth Analg, 2014, 119(5):1194–1200
7. Stamer UM, Stuber F. Genetic factors in pain and its treatment. Curr Opin Anaesthesiol, 2007,20(5):478–484
8. Fernandez-de-las-Penas C, Fernandez-Lao C, Cantarero-Villanueva I, et al. Catechol-O- methyltransferase genotype (Val158met) modulates cancer-related fatigue and pain sensitivity in breast cancer survivors. Breast Cancer Res Treat, 2012,133(2):405–412
9. Lotta T, Vidgren J, Tilgmann C, et al. Kinetics of human soluble and membrane-bound catechol Omethyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry, 1995,34(13):4202–4210
10. Zubieta JK, Heitzeg MM, Smith YR, et al. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science, 2003,299(5610): 1240–1243
11. Ahlers SJ, Elens LL, van Gulik L, et al. The Val158Met polymorphism of the COMT gene is associated with increased pain sensitivity in morphine-treated patients undergoing a painful procedure after cardiac surgery. Br J Clin Pharmacol, 2013,75(6):1506–1515
12. Tammimaki A, Mannisto PT. Catechol-Omethyltransferase gene polymorphism and chronic human pain: a systematic review and meta-analysis. Pharmacogenet Genomics, 2012,22(9):673–691
13. Zhang W, Chang YZ, Kan QC, et al. Association of human micro-opioid receptor gene polymorphism A118G with fentanyl analgesia consumption in Chinese gynaecological patients. Anaesthesia, 2010,65(2):130–135
14. Lopez Soto EJ, Catanesi CI. Human population genetic structure detected by pain-related mu opioid receptor gene polymorphisms. Genet Mol Biol, 2015,38(2):152–155
15. Huang P, Chen C, Mague SD, et al. A common single nucleotide polymorphism A118G of the mu opioid receptor alters its N-glycosylation and protein stability. Biochem J, 2012,441(1):379–386
16. Walter C, Lotsch J. Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment. Pain, 2009,146(3):270–275
17. Gong XD, Wang JY, Liu F, et al. Gene polymorphisms of OPRM1 A118G and ABCB1 C3435T may influence opioid requirements in Chinese patients with cancer pain. Asian Pac J Cancer Prev, 2013,14(5):2937–2943
18. Ochroch EA, Vachani A, Gottschalk A, et al. Natural variation in the mu-opioid gene OPRM1 predicts increased pain on third day after thoracotomy. Clin J Pain, 2012,28(9):747–754
19. Baber M, Chaudhry S, Kelly L, et al. The pharmacogenetics of codeine pain relief in the postpartum period. Pharmacogenomics J, 2015, PMID:25752520
20. Sia AT, Sng BL, Lim EC, et al. The influence of ATP-binding cassette sub-family B member-1 (ABCB1) genetic polymorphisms on acute and chronic pain after intrathecal morphine for caesarean section: a prospective cohort study. Int J Obstet Anesth, 2010,19(3):254–260
21. Fung KL, Gottesman MM. A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function. Biochim Biophys Acta, 2009,1794(5):860–871
22. Hoffmeyer S, Burk O, von Richter O, et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA, 2000,97(7):3473–3478
23. Mamie C, Rebsamen MC, Morris MA, et al. First evidence of a polygenic susceptibility to pain in a pediatric cohort. Anesth Analg, 2013,116(1):170–177
24. Ren ZY, Xu XQ, Bao YP, et al. The impact of genetic variation on sensitivity to opioid analgesics in patients with postoperative pain: a systematic review and meta-analysis. Pain Physician, 2015,18(2):131–152
25. warm R, Abernethy AP, Anghelescu DL, et al. Adult cancer pain. J Natl Compr Canc Netw, 2010,8(9):1046–1086
26. Baclig MO, Predicala RZ, Mapua CA, et al. Allelic and genotype frequencies of catechol-O-methyltransferase (Val158Met) and CYP2D6*10 (Pro34Ser) single nucleotide polymorphisms in the Philippines. Int J Mol Epidemiol Genet, 2012,3(2):115–121
27. Klepstad P, Rakvag TT, Kaasa S, et al. The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease. Acta Anaesthesiol Scand, 2004,48(10):1232–1239
28. Trescot AM, Faynboym S. A review of the role of genetic testing in pain medicine. Pain Physician, 2014,17(5):425–445
29. Gursoy S, Erdal E, Herken H, et al: Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol Int, 2003,23(3):104–107
30. Cargnin S, Magnani F, Viana M, et al. An oppositedirection modulation of the COMT Val158Met polymorphism on the clinical response to intrathecal morphine and triptans. J Pain, 2013,14(10):1097–1106
31. Hagen K, Pettersen E, Stovner LJ, et al. No association between chronic musculoskeletal complaints and Val158Met polymorphism in the Catechol-Omethyltransferase gene. The HUNT study. BMC Musculoskelet Disord, 2006,7:40
32. Fernandez-de-Las-Penas C, Ambite-Quesada S, Gil-Crujera A, et al. Catechol-O-methyltransferase Val158Met polymorphism influences anxiety, depression, and disability, but not pressure pain sensitivity, in women with fibromyalgia syndrome. J Pain, 2012,13(11):1068–1074
33. Diatchenko L, Slade GD, Nackley AG, et al. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet, 2005,14(1):135–143
34. Henker RA, Lewis A, Dai F, et al. The associations between OPRM 1 and COMT genotypes and postoperative pain, opioid use, and opioid-induced sedation. Biol Res Nurs, 2013,15(3):309–317
35. Belfer I, Segall SK, Lariviere WR, et al. Pain modalityand sex-specific effects of COMT genetic functional variants. Pain, 2013,154(8):1368–1376
36. Schroeder JA, Niculescu M, Unterwald EM. Cocaine alters mu but not delta or kappa opioid receptor-stimulated in situ [35S]GTPgammaS binding in rat brain. Synapse, 2003,47(1):26–32
37. Nackley AG, Tan KS, Fecho K, et al. Catechol-Omethyltransferase inhibition increases pain sensitivity through activation of both beta2- and beta3-adrenergic receptors. Pain, 2007,128(3):199–208
38. Bonenberger M, Plener PL, Groschwitz RC, et al. Polymorphism in the micro-opioid receptor gene (OPRM1) modulates neural processing of physical pain, social rejection and error processing. Exp Brain Res, 2015, 233(9):2517–2526
39. Sia AT, Lim Y, Lim EC, et al. A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia. Anesthesiology, 2008,109(3):520–526
40. Fillingim RB, Kaplan L, Staud R, et al. The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. J Pain, 2005,6(3):159–167
41. Chou WY, Wang CH, Liu PH, et al. Human opioid receptor A118G polymorphism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy. Anesthesiology, 2006,105(2):334–337
42. Chou WY, Yang LC, Lu HF, et al. Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty. Acta Anaesthesiol Scand, 2006,50(7):787–792
43. Befort K, Filliol D, Decaillot FM, et al. A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling. J Biol Chem, 2001,276(5):3130–3137
44. Landau R. One size does not fit all: genetic variability of mu-opioid receptor and postoperative morphine consumption. Anesthesiology, 2006,105(2):235–237